- Home
- FGB vs DTIL Comparison
FGB vs DTIL Comparison
Compare FGB & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGB
- DTIL
- Stock Information
- Founded
- FGB 2007
- DTIL 2006
- Country
- FGB United States
- DTIL United States
- Employees
- FGB N/A
- DTIL N/A
- Industry
- FGB Finance/Investors Services
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- FGB Finance
- DTIL Health Care
- Exchange
- FGB Nasdaq
- DTIL Nasdaq
- Market Cap
- FGB 57.5M
- DTIL 51.6M
- IPO Year
- FGB N/A
- DTIL 2019
- Fundamental
- Price
- FGB $4.11
- DTIL $4.79
- Analyst Decision
- FGB
- DTIL Strong Buy
- Analyst Count
- FGB 0
- DTIL 2
- Target Price
- FGB N/A
- DTIL $47.00
- AVG Volume (30 Days)
- FGB 53.0K
- DTIL 85.2K
- Earning Date
- FGB 01-01-0001
- DTIL 07-31-2025
- Dividend Yield
- FGB 8.92%
- DTIL N/A
- EPS Growth
- FGB N/A
- DTIL N/A
- EPS
- FGB N/A
- DTIL N/A
- Revenue
- FGB N/A
- DTIL $51,141,000.00
- Revenue This Year
- FGB N/A
- DTIL N/A
- Revenue Next Year
- FGB N/A
- DTIL $30.20
- P/E Ratio
- FGB N/A
- DTIL N/A
- Revenue Growth
- FGB N/A
- DTIL N/A
- 52 Week Low
- FGB $2.85
- DTIL $3.61
- 52 Week High
- FGB $3.74
- DTIL $11.09
- Technical
- Relative Strength Index (RSI)
- FGB 55.64
- DTIL 44.86
- Support Level
- FGB $3.98
- DTIL $4.20
- Resistance Level
- FGB $4.17
- DTIL $5.29
- Average True Range (ATR)
- FGB 0.06
- DTIL 0.36
- MACD
- FGB -0.00
- DTIL -0.03
- Stochastic Oscillator
- FGB 50.00
- DTIL 36.88
About FGB First Trust Specialty Finance and Financial Opportunities Fund
First Trust Specialty Fnc & Fncl Oppor is a United States-based closed-end management investment company. The Fund's primary investment objective is to seek a high level of current income. It seeks a positive total return as a secondary objective. The Fund seeks to achieve its investment objectives by investing at least 80% of its Managed Assets in a portfolio of securities of specialty finance and other financial companies.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.